AstraZeneca PLC (AZNCF)
136.96
+2.26
(+1.67%)
USD |
OTCM |
Mar 28, 15:53
AstraZeneca Price: 136.96 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 27, 2024 | 133.00 | 135.08 | 133.00 | 134.70 | 2917.00 |
Mar 26, 2024 | 130.25 | 130.55 | 129.50 | 130.55 | 2378.00 |
Mar 25, 2024 | 133.36 | 133.42 | 133.22 | 133.22 | 1229.00 |
Mar 22, 2024 | 134.50 | 134.50 | 132.37 | 132.37 | 1334.00 |
Mar 21, 2024 | 131.00 | 131.00 | 131.00 | 131.00 | 701.00 |
Mar 20, 2024 | 129.50 | 130.99 | 129.50 | 130.99 | 1800.00 |
Mar 19, 2024 | 127.30 | 129.94 | 127.30 | 129.94 | 790.00 |
Mar 18, 2024 | 133.08 | 133.08 | 130.91 | 130.91 | 823.00 |
Mar 15, 2024 | 134.85 | 134.85 | 131.42 | 131.42 | 1045.00 |
Mar 14, 2024 | 135.90 | 135.90 | 131.88 | 134.12 | 1144.00 |
Mar 13, 2024 | 133.53 | 136.40 | 133.53 | 136.40 | 480.00 |
Mar 12, 2024 | 136.06 | 136.06 | 133.32 | 133.32 | 2194.00 |
Mar 11, 2024 | 133.16 | 134.25 | 132.50 | 133.38 | 1757.00 |
Mar 08, 2024 | 133.40 | 133.40 | 131.12 | 131.12 | 1409.00 |
Mar 07, 2024 | 133.45 | 133.45 | 128.78 | 129.25 | 1011.00 |
Mar 06, 2024 | 130.35 | 130.35 | 128.90 | 128.90 | 890.00 |
Mar 05, 2024 | 128.00 | 128.00 | 126.00 | 126.00 | 1721.00 |
Mar 04, 2024 | 128.59 | 129.65 | 127.00 | 129.65 | 1484.00 |
Mar 01, 2024 | 127.38 | 130.00 | 126.25 | 130.00 | 5153.00 |
Feb 29, 2024 | 126.93 | 126.93 | 126.62 | 126.62 | 7341.00 |
Feb 28, 2024 | 131.00 | 131.00 | 131.00 | 131.00 | 0.000 |
Feb 27, 2024 | 127.75 | 131.00 | 127.75 | 131.00 | 965.00 |
Feb 26, 2024 | 133.10 | 133.10 | 129.99 | 129.99 | 1213.00 |
Feb 23, 2024 | 126.50 | 129.71 | 126.50 | 129.15 | 4487.00 |
Feb 22, 2024 | 125.92 | 127.34 | 123.91 | 126.47 | 2399.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
72.75
Minimum
May 31 2019
153.10
Maximum
Apr 24 2023
114.54
Average
115.00
Median
Dec 23 2021
Price Benchmarks
GSK PLC | 42.86 |
Adaptimmune Therapeutics PLC | 1.58 |
Akari Therapeutics PLC | 1.85 |
Biodexa Pharmaceuticals Plc | 1.64 |
Price Related Metrics
PE Ratio | 35.76 |
PS Ratio | 4.670 |
PEG Ratio | 0.4387 |
Price to Book Value | 5.424 |
Price to Free Cash Flow | 32.58 |
Earnings Yield | 2.80% |
Market Cap | 212.31B |
PEGY Ratio | 0.4274 |
Operating PE Ratio | 24.53 |
Normalized PE Ratio | 33.54 |